Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9790201
Piperidine and azepine derivatives as prokineticin receptor modulators
granted -
US 9790285
Anti-CD38 antibodies
granted -
US 9789083
Nitrogen-containing heterocyclic compound
granted -
US 9790220
Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists
granted -
US 9789084
Nitrogen-containing heterocyclic compound
granted -
US 9776962
Aromatic compounds with GPR40 agonistic activity
granted -
US 9777005
Bicyclic heterocyclic compound containing a substituted pyrrole ring
granted -
US 9775827
Nitrogen-containing heterocyclic compound
granted -
US 9770450
4-OXO-3,4-dihydro-1,2,3-benzotriazine as modulators of GPR139
granted -
US 9770452
Quinoxaline derivatives as GPR6 modulators
granted -
US 9757377
Solid preparation
granted -
US 9750748
Pyridazinones as DAAO enzyme inhibitors
granted -
US 9751878
Tetrahydronaphthyridine somatostatin receptor 5 antagonists
granted -
US 9751885
Cyclopropanamine compound and use thereof
granted -
US 9745325
Fused heterocyclic compound
granted -
US 9724339
Methods and drug products for treating alzheimer's disease
granted -
US 9718814
Cyclopropanamine compound and use thereof
granted -
US 9714241
Cyclopropanamine compound and use thereof
granted -
US 9713595
Sustained-release composition and method for producing the same
granted -
US 9708313
Substituted pyrido[3,4-b]pyrazines as GPR6 modulators
granted -
US 9708296
6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
granted -
US 9701623
Di-aliphatic substituted pegylated lipids
granted -
US 9695195
5-HT3 receptor antagonists
granted -
US 9693962
Dry-coated tablet
granted